Le mode conseil est activé Arrêter
Pour la navigation rapide entre les blocs

Organisation: Novo Nordisk
LEI 549300DAQ1CVT6CXN342

Nom de l'organisation
Novo Nordisk A/S
Nom du pays
Danemark
Pays d'enregistrement
Danemark
Secteur économique
Production de médicaments et biotechnologies
Dette obligataire
3.010 millions USD

explorer la base de données la plus complète

800 000

obligations globalement

Plus de 400

sources de prix

80 000

actions

9 000

ETF

suivre votre portefeuille de la manière la plus efficace
screener d'obligations
liste de surveillance
Excel ADD-IN
Obtenir l'accès

Dernières données pour

Cotations

Requête envoyé
Accès refusé
Envoyer la requête
Les cotations fournis par les fournisseurs d’information sont de nature indicative

Profile

Novo Nordisk is a Denmark-based company. It is engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company reports two business segments: Diabetes and Biopharmaceuticals. Diabetes division offers a range of diabetes products, including modern insulins, Biopharmaceuticals division provides treatments for people with haemophilia, growth hormone deficiency and for women experiencing symptoms of menopause / 08.12

Récompenses

Actualités

08/05/2024 Moody's Investors Service revised outlook on Novo Nordisk to positive and affirmed at "A1" (LT- foreign currency) credit rating
08/05/2024 Moody's Ratings affirms Novo Nordisk's A1 rating; changes outlook to positive (Rating action commentary)
12/02/2024 Moody's Investors Service affirms Novo Nordisk at "A1" (LT- foreign currency credit rating); outlook stable
10/02/2024 Moody's affirms Novo Nordisk's A1 rating; outlook stable (Rating action commentary)
26/06/2023 S&P Global Ratings affirms Novo Nordisk at "AA-" (Local Currency LT credit rating); outlook stable
Toutes les actualités de l'organisation

Documents

Etats financiers IFRS / US GAAP

2024
I q ang
2023
I q ang
II q ang
III q ang
IV q ang
2022
I q ang
II q ang
III q ang
IV q ang
2021
I q ang
II q ang
III q ang
IV q ang
2020
I q ang
II q ang
III q ang
IV q ang
2019
I q ang
II q ang
III q ang
IV q ang
2018
I q ang
II q ang
III q ang
IV q ang
Afficher tout Masquer
Il faut s'enregistrer
Envoyer la demande d'accès accès

Actions

Dernières émissions

Montrer tout

Dette obligataire par devise

Montrer tout Cacher

Codes

  • LEI
    549300DAQ1CVT6CXN342
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • CIK
    0000353278

Notations de crédit et notations d’ESG

Macroéconomie

Vous devez vous inscrire pour y accéder.